Katharine Peterson

Chief Accounting Officer at Acrivon Therapeutics · 6 reported transactions in 1 company · latest trade Aug 18, 2026

Their trades


Acrivon TherapeuticsACRV	Sold $203.01 · 101 shares	Aug 18, 2026	S&P 500 +0.3%thru Oct 28

Aug 18, 2026 · ACRV

$203.01

S&P 500 +0.3%thru Oct 28

6 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Chief Accounting Officer at Acrivon Therapeutics · 6 reported transactions in 1 company · latest trade Aug 18, 2026


Acrivon TherapeuticsACRV	Sold $203.01 · 101 shares	Aug 18, 2026	S&P 500 +0.3%thru Oct 28

Aug 18, 2026 · ACRV

$203.01

S&P 500 +0.3%thru Oct 28

6 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.